Ribavirin Can Be Mutagenic for ArenavirusesMORENO, Hector; GALLEGO, Isabel; SEVILLA, Noemi et al.Journal of virology. 2011, Vol 85, Num 14, pp 7246-7255, issn 0022-538X, 10 p.Article

A new tool to study ribavirin-induced haemolysisBROCHOT, Etienne; FRANCOIS, Catherine; CASTELAIN, Sandrine et al.Antiviral therapy (London). 2012, Vol 17, Num 7, pp 1311-1317, issn 1359-6535, 7 p.Article

HPLC―MS/MS method for the intracellular determination of ribavirin monophosphate and ribavirin triphosphate in CEM_ss cellsMELENDEZ, Margarita; ROSARIO, Osvaldo; ZAYAS, Beatriz et al.Journal of pharmaceutical and biomedical analysis. 2009, Vol 49, Num 5, pp 1233-1240, issn 0731-7085, 8 p.Article

Application of inorganic oxidants to the spectrophotometric determination of ribavirin in bulk and capsulesDARWISH, Ibrahim A; KHEDR, Alaa S; ASKAL, Hassan F et al.Journal of AOAC International. 2006, Vol 89, Num 2, pp 341-351, issn 1060-3271, 11 p.Article

Role of epoetin alfa in maintaining ribavirin doseAFDHAL, Nezam H.Gastroenterology clinics of North America. 2004, Vol 33, Num 1S, pp xviii-xix, issn 0889-8553, 12 p., SUPArticle

Spectrophotometric determination of acyclovir and ribavirin in their dosage formsMOHIE KHALED SHARAF EL-DIN; AMINA MOHAMMED EL-BRASHY; ZEINAB AWAD SHERIBAH et al.Journal of AOAC International. 2006, Vol 89, Num 3, pp 631-641, issn 1060-3271, 11 p.Article

Immunopharmacology of CpG oligodeoxynucleotides and ribavirinVOLLMER, Jörg; RANKIN, Robert; HARTMANN, Hanna et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 6, pp 2314-2317, issn 0066-4804, 4 p.Article

Pharmacokinetics, safety, and tolerability of ribavirin in hemodialysis-dependent patientsGUPTA, Samir K; KANTESARIA, Bhavna; GLUE, Paul et al.European journal of clinical pharmacology. 2012, Vol 68, Num 4, pp 415-418, issn 0031-6970, 4 p.Article

dRTP and dPTP a complementary nucleotide couple for the Sequence Saturation Mutagenesis (SeSaM) methodRUFF, Anna Joëlle; MARIENHAGEN, Jan; VERMA, Rajni et al.Journal of molecular catalysis. B, Enzymatic. 2012, Vol 84, pp 40-47, issn 1381-1177, 8 p.Conference Paper

Parainfluenza type 3 infection post stem cell transplant : high prevalence but low mortalityDIGNAN, F; ALVARES, C; RILEY, U et al.The Journal of hospital infection. 2006, Vol 63, Num 4, pp 452-458, issn 0195-6701, 7 p.Article

Pregnancy outcome after exposure to injectable ribavirin during embryogenesisREZVANI, Massoud; KOREN, Gideon.Reproductive toxicology (Elmsford, NY). 2006, Vol 21, Num 1, pp 113-115, issn 0890-6238, 3 p.Article

Factors contributing to ribavirin-induced anemiaNOMURA, Hideyuki; TANIMOTO, Hironori; HAYASHI, Jun et al.Journal of gastroenterology and hepatology. 2004, Vol 19, Num 11, pp 1312-1317, issn 0815-9319, 6 p.Article

Suivi thérapeutique pharmacologique de la ribavirine = Therapeutic drug monitoring of ribavirinSALAS, C; STANKE-LABESQUE, F.La Lettre de l'infectiologue. 2012, Vol 27, Num 2, pp 74-80, issn 0296-9009, 7 p.Article

Ribavirin therapeutic drug monitoring: why, when and how?STANKE-LABESQUE, Françoise; LOUSTAUD-RATTI, Véronique; BABANY, Gérard et al.Fundamental & clinical pharmacology. 2010, Vol 24, Num 4, pp 401-406, issn 0767-3981, 6 p.Article

Ribavirin Enhances Interferon-Stimulated Gene Transcription by Activation of the Interferon-Stimulated Response ElementQIUWEI PAN; TILANUS, Hugo W; JANSSEN, Harry L. A et al.Hepatology (Baltimore, Md.). 2011, Vol 53, Num 4, pp 1400-1401, issn 0270-9139, 2 p.Article

Reduced Ribavirin Antiviral Efficacy via Nucleoside Transporter-Mediated Drug ResistanceIBARRA, Kristie D; PFEIFFER, Julie K.Journal of virology. 2009, Vol 83, Num 9, pp 4538-4547, issn 0022-538X, 10 p.Article

Discontinuation of pegylated interferon plus ribavirin in patients who are not responding to therapy : patients' views of early cessation of therapyD'SOUZA, R; MAIN, J; CROSSEY, M et al.Alimentary pharmacology & therapeutics. 2005, Vol 21, Num 1, pp 43-47, issn 0269-2813, 5 p.Article

La ribavirine = RibavirineDUCLOS-VALLEE, Jean-Charles; SAMUEL, Didier.MTP. Médecine thérapeutique pédiatrie. 2001, Vol 4, Num 1, pp 53-57, issn 1286-5494Article

Adenosine phosphorolyzing enzymes from microorganisms and ribavirin production by the application of the enzymeSHIRAE, H; YOKOZEKI, K; KUBOTA, K et al.Agricultural and biological chemistry. 1991, Vol 55, Num 2, pp 605-607, issn 0002-1369Article

Infections During Peginterferon/Ribavirin Therapy Are Associated With the Magnitude of Decline in Absolute Lymphocyte Count: Results of the IDEAL StudyMELIA, Michael T; BRÄU, Norbert; SCHIFF, Eugene et al.Clinical infectious diseases. 2014, Vol 58, Num 7, pp 960-969, issn 1058-4838, 10 p.Article

Unraveling the genetic predisposition of ribavirin-induced anaemiaASSELAH, Tarik; PASMANT, Eric; LYOUMI, Said et al.Journal of hepatology. 2010, Vol 53, Num 5, pp 971-973, issn 0168-8278, 3 p.Article

Macromolecular Prodrugs of Ribavirin: Concerted Efforts of the Carrier and the DrugSMITH, Anton A. A; WOHL, Benjamin M; KRYGER, Mille B. L et al.Advanced healthcare materials (Print). 2014, Vol 3, Num 9, pp 1404-1407, issn 2192-2640, 4 p.Article

Safety issues related to the administration of ribavirin : An update on respiratory syncytial virusKRILOV, Leonard R.The Pediatric infectious disease journal. 2002, Vol 21, Num 5, pp 479-481, issn 0891-3668Article

The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenaseLEYSSEN, Pieter; BALZARINI, Jan; DE CLERCQ, Erik et al.Journal of virology. 2005, Vol 79, Num 3, pp 1943-1947, issn 0022-538X, 5 p.Article

Antiviral agentsREINES, E. D; GROSS, P. A.The Medical clinics of North America. 1988, Vol 72, Num 3, pp 691-715, issn 0025-7125Article